1. Home
  2. FRSX vs DCOY Comparison

FRSX vs DCOY Comparison

Compare FRSX & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foresight Autonomous Holdings Ltd.

FRSX

Foresight Autonomous Holdings Ltd.

HOLD

Current Price

$2.00

Market Cap

3.5M

Sector

Technology

ML Signal

HOLD

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$5.90

Market Cap

3.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FRSX
DCOY
Founded
N/A
N/A
Country
Israel
United States
Employees
N/A
11
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
3.1M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
FRSX
DCOY
Price
$2.00
$5.90
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$30.00
AVG Volume (30 Days)
37.1K
8.5K
Earning Date
05-15-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$0.53
52 Week High
$3.00
$9.09

Technical Indicators

Market Signals
Indicator
FRSX
DCOY
Relative Strength Index (RSI) 38.24 53.66
Support Level $0.83 $5.28
Resistance Level $2.33 $6.70
Average True Range (ATR) 0.15 0.43
MACD -0.03 -0.03
Stochastic Oscillator 8.21 56.39

Price Performance

Historical Comparison
FRSX
DCOY

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Share on Social Networks: